Lipocine Historical Balance Sheet

LPCN -  USA Stock  

USD 1.14  0.02  1.79%

Trend analysis of Lipocine balance sheet accounts such as Current Assets of 27.4 M provides information on Lipocine's total assets, liabilities, and equity, which is the actual value of Lipocine to its prevalent stockholders. By breaking down trends over time using Lipocine balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year. Financial Statement Analysis is much more than just reviewing and breaking down Lipocine prevalent accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Lipocine is a good buy for the upcoming year.
Additionally, see Stocks Correlation.

Lipocine Historical Statements 

 
Refresh
Share

About Lipocine Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Lipocine at a specified time, usually calculated after every quarter, six months, or one year. Lipocine Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Lipocine and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Lipocine currently owns. An asset can also be divided into two categories, current and non-current.

Lipocine Balance Sheet Chart

Lipocine Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Lipocine uses and utilizes its capital. It also shows what exactly a company owns and owes.
Lipocine Investments are quite stable at the moment as compared to the past year. The company's current value of Investments is estimated at 461,834. Investments Current is expected to rise to about 461.8 K this year, although the value of Accounts Payable will most likely fall to about 972 K.

Total Assets

Total assets refers to the total amount of Lipocine assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Lipocine books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Major components are Cash and Equivalents; Investments; [Intangibles]; Property Plant and Equipment Net; [TaxAssets] and Trade and Non Trade Receivables.

Current Assets

Current assets of Lipocine include cash, cash equivalents, short-term investments, accounts receivable, stock inventory and the portion of prepaid liabilities which will be paid within a year. Depending on the nature of the business, current assets can range from barrels of crude oil, to baked goods, to foreign currency. Current assets are important because they are the assets that are used to fund day-to-day operations of Lipocine. The current portion of Total Assets; reported if a company operates a classified balance sheet that segments current and non-current assets.

Shareholders Equity

A principal component of the balance sheet; in addition to Total Liabilities and Total Assets; that represents the total of all stockholders' equity (deficit) items; net of receivables from officers; directors; owners; and affiliates of the entity which are attributable to the parent.

Total Liabilities

Deferred Income Tax is recorded on Lipocine balance sheet and a result of income already earned and recognized for accounting, but not tax, purposes. Also, differences between tax laws and accounting methods can result in a temporary difference in the amount of income tax payable by a company. This difference is recorded on Lipocine books as deferred income tax. Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Principal components are Total Debt; [DeferredRev]; Trade and Non Trade Payables; Deposit Liabilities; and Tax Liabilities.
Most accounts from Lipocine balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Lipocine current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Additionally, see Stocks Correlation.Lipocine Investments are quite stable at the moment as compared to the past year. The company's current value of Investments is estimated at 461,834. Investments Current is expected to rise to about 461.8 K this year, although the value of Accounts Payable will most likely fall to about 972 K.
 2018 2019 2020 2021 (projected)
Accounts Payable671.28 K1.18 M1.06 M972.03 K
Receivables38.51 K16.52 K19 K19.5 K

Lipocine balance sheet Correlations

-0.5-0.12-0.120.420.080.630.490.630.160.840.840.49-0.81-0.82-0.43-0.560.360.490.49
-0.50.250.25-0.09-0.04-0.07-0.04-0.070.13-0.2-0.2-0.040.350.650.40.990.05-0.04-0.04
-0.120.251.00.410.77-0.08-0.12-0.080.94-0.08-0.07-0.120.180.380.770.260.07-0.12-0.12
-0.120.251.00.410.77-0.08-0.12-0.080.94-0.08-0.08-0.120.180.380.770.260.07-0.12-0.12
0.42-0.090.410.41-0.010.390.310.390.530.470.470.31-0.31-0.130.16-0.140.540.310.31
0.08-0.040.770.77-0.01-0.26-0.28-0.260.72-0.15-0.16-0.280.140.190.480.0-0.34-0.28-0.28
0.63-0.07-0.08-0.080.39-0.260.871.00.170.870.870.87-0.67-0.65-0.05-0.20.730.870.87
0.49-0.04-0.12-0.120.31-0.280.870.860.050.730.731.0-0.41-0.550.12-0.180.581.01.0
0.63-0.07-0.08-0.080.39-0.261.00.860.170.870.870.86-0.67-0.65-0.05-0.20.730.860.86
0.160.130.940.940.530.720.170.050.170.250.250.05-0.160.090.620.120.310.050.05
0.84-0.2-0.08-0.080.47-0.150.870.730.870.251.00.73-0.9-0.8-0.25-0.30.760.730.73
0.84-0.2-0.07-0.080.47-0.160.870.730.870.251.00.73-0.9-0.8-0.24-0.30.760.730.73
0.49-0.04-0.12-0.120.31-0.280.871.00.860.050.730.73-0.41-0.550.12-0.180.581.01.0
-0.810.350.180.18-0.310.14-0.67-0.41-0.67-0.16-0.9-0.9-0.410.860.490.41-0.66-0.41-0.41
-0.820.650.380.38-0.130.19-0.65-0.55-0.650.09-0.8-0.8-0.550.860.510.72-0.43-0.55-0.55
-0.430.40.770.770.160.48-0.050.12-0.050.62-0.25-0.240.120.490.510.360.070.120.12
-0.560.990.260.26-0.140.0-0.2-0.18-0.20.12-0.3-0.3-0.180.410.720.36-0.04-0.18-0.18
0.360.050.070.070.54-0.340.730.580.730.310.760.760.58-0.66-0.430.07-0.040.580.58
0.49-0.04-0.12-0.120.31-0.280.871.00.860.050.730.731.0-0.41-0.550.12-0.180.581.0
0.49-0.04-0.12-0.120.31-0.280.871.00.860.050.730.731.0-0.41-0.550.12-0.180.581.0
Click cells to compare fundamentals

Lipocine Account Relationship Matchups

Lipocine balance sheet Accounts

201620172018201920202021 (projected)
Receivables38.94 K23.07 K38.51 K16.52 K19 K19.5 K
Accounts Payable245.91 K4.85 M671.28 K1.18 M1.06 M972.03 K
Accumulated Other Comprehensive Income(8.49 K)(4.62 K)(963)(38.0)(43.7)(47.15)
Total Assets27.34 M25.33 M20.85 M19.66 M25.35 M27.45 M
Current Assets27.21 M25.22 M20.81 M19.63 M25.33 M27.37 M
Assets Non Current134.19 K105.82 K42.75 K27.31 K23.75 K24.38 K
Cash and Equivalents5.56 M3.21 M13.08 M14.73 M24.22 M21.96 M
Cash and Equivalents USD5.56 M3.21 M13.08 M14.73 M24.22 M21.96 M
Shareholders Equity26.02 M18.98 M9.43 M6.29 M15.34 M16.27 M
Shareholders Equity USD26.02 M18.98 M9.43 M6.29 M15.34 M16.27 M
Investments21.28 M18.26 M7.17 M4.34 M449.99 K461.83 K
Investments Current21.28 M18.26 M7.17 M4.34 M449.99 K461.83 K
Total Liabilities1.33 M6.35 M11.42 M13.37 M10.01 M8.11 M
Current Liabilities1.33 M6.35 M4.49 M4.96 M6.58 M5.22 M
Trade and Non Trade Payables245.91 K4.85 M671.28 K1.18 M1.6 M1.45 M
Property Plant and Equipment Net103.44 K75.07 K19 K3.55 K3.2 K3.28 K
Accumulated Retained Earnings Deficit(105.42 M)(126.4 M)(138.06 M)(151.07 M)(172.03 M)(176.56 M)

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lipocine without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Headlines Timeline Now

   

Headlines Timeline

Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lipocine using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Stocks Correlation. Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Lipocine Stock analysis

When running Lipocine price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine Lipocine value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.